Latest / Pediatric Nutrition Insights / Pediatric Cough Syrups Why This Category Belongs in Every Franchise Portfolio

Transcript

Pediatric Cough Syrups Why This Category Belongs in Every Franchise Portfolio · Pediatric Nutrition Insights

• 0:00
  Speaker 1: Imagine spending millions of dollars right just perfectly engineering a drug.
• 0:05
  Speaker 1: You get it approved, you source the absolute best raw materials,
• 0:09
  Speaker 1: and you calibrate the whole manufacturing process down to like
• 0:12
  Speaker 1: the fraction of a millimeterate a massive investment, exactly, and
• 0:16
  Speaker 1: you put it on the shelf expecting this huge return
• 0:18
  Speaker 1: on investment, only for your entire pharmaceutical empire to just
• 0:21
  Speaker 1: crumble because the three year old decides they don't like
• 0:24
  Speaker 1: the cherry flavor.
• 0:25
  Speaker 2: Yeah, that is the reality of it. It's wild, It is.
• 0:28
  Speaker 1: Wild, and that high stakes reality a pediatric medicine is
• 0:31
  Speaker 1: exactly what we're getting into today. Welcome to the deep dive.
• 0:34
  Speaker 2: Everyone glad to be here.
• 0:36
  Speaker 1: So today we are unpacking this brief but honestly incredibly
• 0:40
  Speaker 1: dense set of insights from a pediatric nutrition and pharmaceutical overview,
• 0:45
  Speaker 1: and we're focusing on something that you know, to you
• 0:48
  Speaker 1: listening probably seems totally mundanea for his clients pediatric cough syrups.
• 0:52
  Speaker 2: Yeah, and it really is a fascinating market precisely because
• 0:55
  Speaker 2: it just shatters all our assumptions. I mean, we inherently
• 0:57
  Speaker 2: want to believe that something is common as a cough
• 0:59
  Speaker 2: syrup is just a ubiquitous, one size fits all commodity.
• 1:04
  Speaker 1: Right, Like you get sick, you walk down the pharmacy al,
• 1:06
  Speaker 1: you grab a bottle and that's it. Simple transaction exactly.
• 1:10
  Speaker 2: But for the pharmaceutical franchise partner is actually operating in
• 1:13
  Speaker 2: this space, understanding the deep intricate nuances of this specific
• 1:18
  Speaker 2: product category is literally the difference between capturing a thriving
• 1:22
  Speaker 2: market and leaving just massive amounts of prescriptions on the table.
• 1:26
  Speaker 1: It's a ruthless business environment, oh, totally unforgiving. And the
• 1:30
  Speaker 1: sources we are looking at today they make it very
• 1:33
  Speaker 1: clear that to survive in this market as a franchise partner,
• 1:37
  Speaker 1: you really have to master three entirely different disciplines at
• 1:40
  Speaker 1: the exact same time. You need the chemistry, you need
• 1:43
  Speaker 1: the engineering, and you need a pretty deep understanding of
• 1:47
  Speaker 1: Toddler psychology.
• 1:48
  Speaker 2: Yeah, that last one is the kicker.
• 1:50
  Speaker 1: Let's start with the chemistry, though, because obviously you can't
• 1:52
  Speaker 1: sell a product if you don't actually understand the fundamental
• 1:55
  Speaker 1: physical problem it's trying to solve inside the human body.
• 1:59
  Speaker 2: Right. The biology dictates everything else, right.
• 2:02
  Speaker 1: And the sources draw this very strict line in the sand.
• 2:05
  Speaker 1: All coughs are not created equal. There is a really
• 2:09
  Speaker 1: rigid formulation divide between wet coughs and dry coughs.
• 2:12
  Speaker 2: Yeah, the biological reality is incredibly rigid here. I mean,
• 2:16
  Speaker 2: we casually use the word cough in our everyday lives
• 2:18
  Speaker 2: as just this catch all term for anytime we know
• 2:21
  Speaker 2: hack something up. True, but chemically there are entirely different
• 2:25
  Speaker 2: mechanisms at play inside the lungs and the throat. So
• 2:28
  Speaker 2: the source material outlines two primary categories that basically dictate
• 2:32
  Speaker 2: the entire manufacturing inventory and prescribing process.
• 2:36
  Speaker 1: Okay, so let's break those down.
• 2:37
  Speaker 2: First, you have the wet cough, which fundamentally requires a
• 2:40
  Speaker 2: specific class of drugs called mucolytics.
• 2:43
  Speaker 1: Right, and the specific mucultics mentioned in our sources are
• 2:46
  Speaker 1: ambroxol and gwifenessen. So what is actually happening biologically when
• 2:51
  Speaker 1: a child takes one of those? Like, what are they doing?
• 2:54
  Speaker 2: Okay? So think of wet mucus in the chest like
• 2:56
  Speaker 2: a thick, tangled, sticky net of proteins. It's trapping bacteria,
• 3:01
  Speaker 2: which is good, but it's too dense for the body
• 3:03
  Speaker 2: to actually expel. So a mucolytic like ambroxol acts essentially
• 3:08
  Speaker 2: like a pair of chemical scissors.
• 3:10
  Speaker 1: Chemical scissors, Yeah.
• 3:11
  Speaker 2: It physically travels into the respiratory tract and breaks the
• 3:15
  Speaker 2: disulfide bonds that are holding that sticky net together. It
• 3:18
  Speaker 2: thins the mucus out, changes its viscosity.
• 3:21
  Speaker 1: Basically, Oh wow, so it's breaking it down so the
• 3:23
  Speaker 1: body can actually handle it exactly.
• 3:25
  Speaker 2: Once it's thinned out, the body's natural microscopic hairs, the
• 3:29
  Speaker 2: cilia can actually sweep it up and out of the airway.
• 3:32
  Speaker 2: It's a very active mechanical clearing mechanism.
• 3:35
  Speaker 1: Okay, so you are actively dissolving the blockage. But then
• 3:39
  Speaker 1: on the complete opposite side of the spectrum, the sources
• 3:41
  Speaker 1: bring up the dry costs.
• 3:42
  Speaker 2: Right, totally different beasts, and for.
• 3:44
  Speaker 1: A dry cough, the required approach is a suppressant, specifically
• 3:48
  Speaker 1: the source's name love a drop propazine or dextromethorphin. So
• 3:54
  Speaker 1: if mucalytics are our chemical scissors, what exactly are suppressants doing.
• 3:58
  Speaker 2: Suppressants operate on a completely different pathway. A dry cough
• 4:02
  Speaker 2: isn't about trapped, thick mucus. It's usually about raw irritation
• 4:06
  Speaker 2: or just a hyperactive reflex.
• 4:08
  Speaker 1: So there's nothing to actually cut through.
• 4:09
  Speaker 2: Or clear out exactly. Suppressants aren't trying to clear anything.
• 4:14
  Speaker 2: Their job is to calm the nervous system's response to
• 4:17
  Speaker 2: that irritation. How do they do that well, depending on
• 4:21
  Speaker 2: the formulation, they either numb the stretch receptors in the
• 4:24
  Speaker 2: respiratory track so they literally don't feel the tickle, or
• 4:27
  Speaker 2: they gently signal the brain's cough center to just temporarily
• 4:32
  Speaker 2: ignore the urge to cough.
• 4:34
  Speaker 1: Got it, So they are soothing the alarm system rather
• 4:37
  Speaker 1: than fighting a physical blockage.
• 4:39
  Speaker 2: You hit the nail on the head.
• 4:40
  Speaker 1: That's exactly it, which honestly makes treating a wet cough
• 4:43
  Speaker 1: with a dry cough suppressant sound like a terrible idea.
• 4:47
  Speaker 2: Yeah.
• 4:47
  Speaker 1: I mean it would be like putting a piece of
• 4:49
  Speaker 1: duct tape over a blaring fire alarm instead of actually
• 4:51
  Speaker 1: putting out the fire in the kitchen.
• 4:53
  Speaker 2: That is a perfect analogy, right, You're.
• 4:55
  Speaker 1: Just masking the irritation in the noise, but you aren't
• 4:58
  Speaker 1: doing anything to clear the actual have You're basically just
• 5:01
  Speaker 1: trapping the bad stuff in the lungs.
• 5:03
  Speaker 2: Yeah, and if you suppress a cough that is biologically
• 5:06
  Speaker 2: designed to expel thick infected congestion. You are directly working
• 5:10
  Speaker 2: against the bodder's essential defense.
• 5:12
  Speaker 1: Mechanisms, making the kid even sicker.
• 5:15
  Speaker 2: Right, you are actively making the child worse. And this
• 5:18
  Speaker 2: physical reality, it translates directly into a massive business vulnerability
• 5:23
  Speaker 2: for anyone supplying these medications.
• 5:26
  Speaker 1: Okay, wait, I have stop you there and play Devil's
• 5:28
  Speaker 1: Advocate for a second.
• 5:29
  Speaker 2: Sure, go for it.
• 5:29
  Speaker 1: From a pure overhead perspective, right, stalking two entirely different
• 5:34
  Speaker 1: lines of complex medicine for essentially the same broad symptom.
• 5:39
  Speaker 1: It sounds like an inventory nightmare.
• 5:41
  Speaker 2: Oh, it definitely is more complex.
• 5:43
  Speaker 1: So if I'm a new franchise partner and I'm looking
• 5:45
  Speaker 1: at my spreadsheets, what happens if I just decide to
• 5:48
  Speaker 1: buy a massive cheap barrel of some generic dry cough
• 5:52
  Speaker 1: suppressant and push that to all my pharmacy clients. I mean,
• 5:55
  Speaker 1: who's actually going to stop me from taking the easy route?
• 5:57
  Speaker 2: Well, the ultimate gatekeeper of the medical legal system is
• 6:00
  Speaker 2: going to stop you, and that's the pediatrician.
• 6:03
  Speaker 1: Ah right, the doctors.
• 6:05
  Speaker 2: Yeah, the doctor knows the fundamental chemical difference between breaking
• 6:08
  Speaker 2: disulfide bonds and numbing a nerve reflex. They're the ones
• 6:12
  Speaker 2: diagnosing the specific sound and origin of that child's cough
• 6:15
  Speaker 2: in the clinic.
• 6:16
  Speaker 1: So they aren't going to just settle for whatever you
• 6:18
  Speaker 1: happen to have on the shelf.
• 6:19
  Speaker 2: Never, if they determine a child needs a eucolitic and
• 6:23
  Speaker 2: your franchise only supplies the pressence to that local pharmacy,
• 6:26
  Speaker 2: the doctor doesn't just shrug and alter their medical opinion
• 6:29
  Speaker 2: to accommodate your limited inventory.
• 6:31
  Speaker 1: They just bypass you entirely.
• 6:33
  Speaker 2: Exactly, They actively route their patients elsewhere. And honestly, it's
• 6:37
  Speaker 2: worse than just losing a single sale helf, so well
• 6:41
  Speaker 2: stalking the wrong composition or even just an incomplete range.
• 6:45
  Speaker 2: It signals to the medical community that you, as a
• 6:48
  Speaker 2: franchise partner, do not understand fundamental clinical needs.
• 6:52
  Speaker 1: Oh so, your reputation takes a hit, a huge hit.
• 6:54
  Speaker 2: You lose credibility instantly. Pediatricians will just stop writing scripts
• 6:59
  Speaker 2: that match your catalog, and you lose a significant chunk
• 7:02
  Speaker 2: of potential prescriptions across the board. The chemistry literally dictates
• 7:06
  Speaker 2: your business survival.
• 7:07
  Speaker 1: Okay, so say you're listening to this and you're a
• 7:10
  Speaker 1: franchise partner. You've done your homework, You've sourced the exact
• 7:13
  Speaker 1: right mucolitic for the wet coughs and the perfect suppressant
• 7:16
  Speaker 1: for the dry coughs. You have the chemical scissors and
• 7:19
  Speaker 1: the alarm suitors ready to go. You're off to a
• 7:21
  Speaker 1: good start, right, But reading through these sources, getting the
• 7:25
  Speaker 1: chemistry right is really only phase one, because the right
• 7:28
  Speaker 1: medicine is totally useless if the delivery mechanism isn't calibrated
• 7:32
  Speaker 1: perfectly to the patient's rapidly changing body.
• 7:34
  Speaker 2: Right. The container matters just as much as the liquid.
• 7:37
  Speaker 1: Yeah, So let's move into the engineering side of this,
• 7:40
  Speaker 1: the age and dosing dilemma.
• 7:42
  Speaker 2: This is a huge hurdle. The physical container and the
• 7:45
  Speaker 2: concentration of the liquid inside it are just as critical
• 7:48
  Speaker 2: as the act of pharmaceutical ingredient itself.
• 7:51
  Speaker 1: And the sources break this engineering challenge down into three distinct,
• 7:55
  Speaker 1: non negotiable tears right, based entirely on the age and
• 7:59
  Speaker 1: metabolic capacity.
• 8:00
  Speaker 2: Of the child exactly. First, you have the infant tier.
• 8:04
  Speaker 2: For infants, the formulation absolutely must be engineered as calibrated
• 8:08
  Speaker 2: drop syrups.
• 8:09
  Speaker 1: Yeah, and if you ever tried to give a squirming,
• 8:11
  Speaker 1: screaming infant medicine at three am in a dark kitchen.
• 8:15
  Speaker 1: You know exactly why this matters. We're talking about highly
• 8:19
  Speaker 1: precise micro level dosing here.
• 8:21
  Speaker 2: We really are. I mean, an infant's liver and kidneys
• 8:23
  Speaker 2: are still developing, so they process drugs very differently than
• 8:26
  Speaker 2: an older child.
• 8:27
  Speaker 1: You can't just guess.
• 8:28
  Speaker 2: No, you cannot estimate a dose. The dropper provides exactly
• 8:32
  Speaker 2: the fraction of a milligram required for their specific body weight.
• 8:35
  Speaker 1: Okay, so that's infants.
• 8:37
  Speaker 2: Then as the child grows into the toddler tear, the
• 8:39
  Speaker 2: physical product has to morph ag in. Toddlers require small
• 8:43
  Speaker 2: volume syrups, and the sources emphasize a very strict.
• 8:46
  Speaker 1: Manufacturing rule here, which.
• 8:48
  Speaker 2: Is these toddler formulations must be strictly alcohol free. That
• 8:52
  Speaker 2: is non negotiable.
• 8:54
  Speaker 1: Got it. And then finally you have the older children
• 8:56
  Speaker 1: who sort of graduate up to those standard sixty to
• 8:59
  Speaker 1: one hundred milliliter bottles that we are all used to
• 9:02
  Speaker 1: seeing lining the shelves at the local pharmacy.
• 9:04
  Speaker 2: That's the progression drops for infants, small alcohol free volumes
• 9:08
  Speaker 2: for toddlers, and standard larger bottles for the older kids.
• 9:12
  Speaker 1: Okay, so I'm putting myself in the shoes of a
• 9:14
  Speaker 1: business owner again here, and I'm looking at the cost
• 9:17
  Speaker 1: of all this bottling and packaging. It adds up fast, right,
• 9:20
  Speaker 1: So why go through the massive headache of creating three
• 9:23
  Speaker 1: entirely separate product lines, Like, couldn't a stress parent just
• 9:27
  Speaker 1: take the older kids standard one hundred mili liter bottle,
• 9:31
  Speaker 1: pour out a tiny, tiny, microscopic sip and give it
• 9:34
  Speaker 1: to their two year old toddler just to save time
• 9:37
  Speaker 1: and money. I mean, why does the bottle absolutely have
• 9:40
  Speaker 1: to change.
• 9:40
  Speaker 2: It's a fair question, and that instinct to consolidate is
• 9:44
  Speaker 2: super common in normal retail. But in pharmaceutical practice, that
• 9:48
  Speaker 2: one size fits all approach is a total failure on
• 9:51
  Speaker 2: a clinical safety.
• 9:52
  Speaker 1: Level because of the concentration.
• 9:54
  Speaker 2: Exactly, you cannot, just like eyeball a smaller physical amount
• 9:58
  Speaker 2: of a medication design for a ten year old and
• 10:01
  Speaker 2: safely administer it to a two year old. The concentration
• 10:03
  Speaker 2: density is fundamentally different.
• 10:05
  Speaker 1: Give me an example of how that breaks down.
• 10:07
  Speaker 2: Sure, a ten year old's formula might have fifteen milligrams
• 10:10
  Speaker 2: of an active ingredient packed into every five millilters of liquid,
• 10:14
  Speaker 2: but a toddler's body might only be able to safely
• 10:17
  Speaker 2: handle five milligrams total. Yeah, so trying to visually measure
• 10:21
  Speaker 2: out a third of a teaspoon in the middle of
• 10:23
  Speaker 2: the night when you're exhausted is just a recipe for
• 10:27
  Speaker 2: an accidental overdose, not to.
• 10:28
  Speaker 1: Mention the ingredients themselves. Right, like you said earlier, Giving
• 10:32
  Speaker 1: a toddler a syrup that uses alcohol as a solvent,
• 10:36
  Speaker 1: which is sometimes acceptable for older kids, that has to
• 10:39
  Speaker 1: be a massive red flag.
• 10:41
  Speaker 2: A massive red flag a pediatrician will intercept that immediately.
• 10:45
  Speaker 2: Medical professionals actively look for these exact age appropriate formulations.
• 10:49
  Speaker 2: They want to see the calibrated droppers, the alcohol free
• 10:52
  Speaker 2: labels because precision and safety they're non negotiable.
• 10:56
  Speaker 1: So the delivery mechanism isn't just marketing.
• 10:59
  Speaker 2: No, the physical bottle and the concentration inside it are
• 11:01
  Speaker 2: an integral part of the medicine safety profile. You cannot
• 11:05
  Speaker 2: separate the chemistry from the packaging. If a franchise partner
• 11:08
  Speaker 2: tries to push a generic large bottle for a toddler,
• 11:10
  Speaker 2: market doctors will simply refuse to prescribe it.
• 11:13
  Speaker 1: Wow, Okay, So to recap this gauntlet so far, Yeah,
• 11:15
  Speaker 1: a successful franchise partner has to solve the conplex biological
• 11:19
  Speaker 1: chemistry of wet versus dry coughs. Then they have to
• 11:22
  Speaker 1: simultaneously scale all of that chemistry into perfectly engineered packaging
• 11:28
  Speaker 1: droppers for the infants, alcohol free, small volumes for the toddlers,
• 11:32
  Speaker 1: and large bottles for the older kids.
• 11:34
  Speaker 2: It is a logistical mountain to climb.
• 11:36
  Speaker 1: It really is. But honestly, here is the wildest part
• 11:40
  Speaker 1: of this entire deep dive. You can have the most
• 11:42
  Speaker 1: scientifically advanced tembroxile, you can package it in a perfectly
• 11:46
  Speaker 1: calibrated sterile, alcohol free five milli liter dropper.
• 11:51
  Speaker 2: If pharmaceutical masterpiece.
• 11:52
  Speaker 1: Exactly chemically and structurally, it's perfect. But all of that
• 11:56
  Speaker 1: science hits an absolute brick wall if the child simply
• 11:59
  Speaker 1: refuses to swallow.
• 12:00
  Speaker 2: Yeah, that is the ultimate test, which brings us.
• 12:02
  Speaker 1: To the ultimate gatekeeper of the entire pharmaceutical supply chain,
• 12:05
  Speaker 1: the toddler.
• 12:06
  Speaker 2: This is where pristine laboratory science collides violently with the
• 12:09
  Speaker 2: chaotic reality of human behavior. It's the Toddler feedback loop.
• 12:14
  Speaker 1: I just I find the irony of this so incredible.
• 12:16
  Speaker 1: You have this multimillion dollar global pharmaceutical infrastructure, right, you
• 12:21
  Speaker 1: have scientists in pristine labs breaking down to sulfide bonds.
• 12:24
  Speaker 2: Decades of research, decades.
• 12:26
  Speaker 1: And massive manufacturing plants, calibrating drop serfs to the exact millimeter,
• 12:32
  Speaker 1: and all of that infrastructure, all of that capital investment
• 12:35
  Speaker 1: ultimately bows down to the taste buds of a grumpy
• 12:38
  Speaker 1: three year old sitting in a high chair, crossing their
• 12:40
  Speaker 1: arms and just refusing to open their mouth.
• 12:43
  Speaker 2: It's hilarious, but it is a profound example of bottom
• 12:47
  Speaker 2: up economics dictating an entire industry. Curiously, the sources we
• 12:51
  Speaker 2: are analyzing are incredibly clear on this specific point. Taste
• 12:56
  Speaker 2: is the primary driver of brand switching in the pediatric
• 12:59
  Speaker 2: syrup category.
• 13:00
  Speaker 1: So it's not just a nice to have.
• 13:02
  Speaker 2: No palatability is not just some nice marketing bonus feature.
• 13:05
  Speaker 2: It is the functional lynchpin of the entire medical outcome.
• 13:09
  Speaker 1: Right, Because if a kid spits out a bitter, poorly
• 13:11
  Speaker 1: flavored syrup, I'm assuming the parent doesn't just give up
• 13:14
  Speaker 1: and let the kid com for two weeks. Of course,
• 13:15
  Speaker 1: that they probably call the doctor demanding a refill of
• 13:18
  Speaker 1: something else. And suddenly, you, the franchise owner who stocked
• 13:21
  Speaker 1: the bad tasting, heavily engineered medicine, you are entirely cut
• 13:26
  Speaker 1: out of the loop.
• 13:26
  Speaker 2: The feedback loop is lightning fast and totally unforgiving. Let's
• 13:30
  Speaker 2: just trace the steps real quick.
• 13:32
  Speaker 1: Yeah, walk us through it.
• 13:33
  Speaker 2: You supply a highly effective, scientifically superior eucoltic, right, but
• 13:39
  Speaker 2: it has a harsh kind of metallic aftertaste.
• 13:43
  Speaker 1: Okay.
• 13:43
  Speaker 2: The parent buys it, wrestles with their tonneler to take it,
• 13:47
  Speaker 2: and the child vomits it back up or just flat
• 13:50
  Speaker 2: out refuses.
• 13:51
  Speaker 1: Sound like a nightmare.
• 13:52
  Speaker 2: It is, And that parent, who is already exhausted and worried,
• 13:55
  Speaker 2: is not going to force feed their child for a week.
• 13:58
  Speaker 2: They immediately call the pediatric and say, look, my kid
• 14:01
  Speaker 2: will not take this medicine.
• 14:03
  Speaker 1: And the doctor obviously knows better than to tell a
• 14:05
  Speaker 1: tired parent to just, you know, fight their toddler harder.
• 14:08
  Speaker 2: Oh. Absolutely, the doctor drops your brand instantly. They write
• 14:11
  Speaker 2: a new prescription for a competitor's brand that is known
• 14:14
  Speaker 2: in the market to be more palatable, maybe like a
• 14:17
  Speaker 2: well formulated strawberry or a mixed fruit flavor.
• 14:20
  Speaker 1: Wow, just like that, Just.
• 14:22
  Speaker 2: Like that, Because in pediatrics a fundamental law of medical
• 14:25
  Speaker 2: economics applies. A medicine that is actually swallowed by the
• 14:29
  Speaker 2: patient is worth infinitely more than a medically superior compound
• 14:32
  Speaker 2: that is just sitting unused in a bathroom cabinet.
• 14:35
  Speaker 1: Because if there's zero compliance, there is zero clinical efficacy zack,
• 14:40
  Speaker 1: which means, if you are a franchise partner listening to this,
• 14:44
  Speaker 1: you could do everything else perfectly right. You meticulously stock
• 14:48
  Speaker 1: all the right eucalytics and suppressants, you ensure all the
• 14:51
  Speaker 1: packaging is age.
• 14:52
  Speaker 2: Appropriate, but it won't matter right.
• 14:54
  Speaker 1: Because if you don't aggressively prioritize the taste profile of
• 14:57
  Speaker 1: your inventory, you're perfectly engineered. Are just going to gather dust.
• 15:02
  Speaker 1: In this highly regulated medical space, the end user literally
• 15:06
  Speaker 1: holds all the market power, even if that end user
• 15:09
  Speaker 1: happens to be wearing diapers.
• 15:10
  Speaker 2: It is a dual mandate that simply cannot be ignored.
• 15:14
  Speaker 2: You have to satisfy the doctor's rigid requirement for clinical
• 15:17
  Speaker 2: efficacy and safety while simultaneously satisfying the child's emotional requirement
• 15:21
  Speaker 2: for a tolerable flavor.
• 15:23
  Speaker 1: And if you fail at either one.
• 15:24
  Speaker 2: Your product fails in the market period.
• 15:26
  Speaker 1: Okay, so this brings us to the ultimate operational question
• 15:29
  Speaker 1: for you listening Knowing that a franchise partner has to
• 15:33
  Speaker 1: survive this intense gauntlet, the strict chemical pathways, the varied
• 15:37
  Speaker 1: metabolic age requirements, and this ruthless Toddler taste test. It's
• 15:43
  Speaker 1: a lot to juggle, it really is. So how does
• 15:45
  Speaker 1: a business actually source inventory that checks every single one
• 15:49
  Speaker 1: of these boxes without going bankrupt? We know the scope
• 15:53
  Speaker 1: of the problem. Now let's look at the manufacturing solution
• 15:56
  Speaker 1: that was highlighted in the sources.
• 15:57
  Speaker 2: Oh, let's talk about how you actually pull this off.
• 16:00
  Speaker 1: Next points specifically to a model used by a company
• 16:02
  Speaker 1: called Pdvents.
• 16:03
  Speaker 2: Yeah. So, to navigate a market this complex, a successful
• 16:07
  Speaker 2: business looks for manufacturing partners that have already solved these
• 16:11
  Speaker 2: layered problems down at the factory.
• 16:12
  Speaker 1: Floor level, making it someone else's headache.
• 16:14
  Speaker 2: Basically, Yes, pd Events is highlighted in the text as
• 16:18
  Speaker 2: manufacturing over eight different specialized formulations of pediatric cough syrups.
• 16:22
  Speaker 1: Wow.
• 16:23
  Speaker 2: Eight Yeah, And that breadth is crucial because it natively
• 16:27
  Speaker 2: covers that entire spectrum we just spent all this time unpacking.
• 16:31
  Speaker 2: You know, the specific nucalytics for the wet coughs, the
• 16:34
  Speaker 2: targeted suppressants for the dry coughs, and even combination ranges.
• 16:38
  Speaker 2: And they are all pre engineered.
• 16:40
  Speaker 1: And according to the sources, they're hitting the strict safety
• 16:42
  Speaker 1: requirements too, right, Like they're alcohol free and sugar free. Yes,
• 16:46
  Speaker 1: all the above, but the text also mentions they are
• 16:49
  Speaker 1: who GMP certified. Now, what does that acronym actually mean
• 16:54
  Speaker 1: for the medicine inside the bottle?
• 16:56
  Speaker 2: Okay, so WHOGMP stands for World Health Organization Good Manufacturing Practices.
• 17:02
  Speaker 1: Sounds official, very official, and.
• 17:04
  Speaker 2: It isn't just some generic stamp of approval either. It
• 17:07
  Speaker 2: represents a massive operational reality likeway. It means the facility
• 17:11
  Speaker 2: operates with speral air locks, constant microbial batch testing, and
• 17:16
  Speaker 2: rigorous raw material tracing. It ensures that the ambroxal manufactured
• 17:20
  Speaker 2: on a Tuesday is exactly as pure and concentrated as
• 17:23
  Speaker 2: the embroxal manufactured on a.
• 17:25
  Speaker 1: Friday with zero cross contamination zero.
• 17:28
  Speaker 2: And this is why over five hundred farmer brands trust
• 17:31
  Speaker 2: a facility like this. They are basically outsourcing the massive
• 17:34
  Speaker 2: headache of regulatory compliance and safety metrics so the franchise
• 17:38
  Speaker 2: partner can just focus on distribution.
• 17:40
  Speaker 1: That makes total sense, But there is one specific metric
• 17:43
  Speaker 1: mentioned in the text that really stood out as a
• 17:45
  Speaker 1: game changer to someone actually trying to run a business. Here.
• 17:47
  Speaker 1: Oh the MOQ, Yes, the minimum order quantity or MOQ.
• 17:52
  Speaker 1: The sources state that their MOQ starts at just five
• 17:55
  Speaker 1: hundred to one thousand units per SKIU. Now, in the
• 17:59
  Speaker 1: grand scheme of global factory manufacturing, five hundred units sounds
• 18:03
  Speaker 1: like a tiny drop in the bucket.
• 18:05
  Speaker 2: It is very small for this industry.
• 18:06
  Speaker 1: So why is that specific low MOQ metric so incredibly
• 18:12
  Speaker 1: vital for a franchise partner.
• 18:13
  Speaker 2: Well, if we look at this as an economic case
• 18:16
  Speaker 2: study and supply chain agility, that low MOQ is the
• 18:19
  Speaker 2: absolute key to market access.
• 18:22
  Speaker 1: Because normally you'd have to buy way more.
• 18:24
  Speaker 2: Exactly, traditional pharmaceutical manufacturing requires massive bulk runs. We're talking
• 18:29
  Speaker 2: often ten thousand to fifty thousand units.
• 18:31
  Speaker 1: Per product just to get them to turn the machines
• 18:33
  Speaker 1: on right.
• 18:34
  Speaker 2: Because setting up those machines, sterilizing the vats, and cleaning
• 18:37
  Speaker 2: all the lines for a new chemical formula is incredibly
• 18:40
  Speaker 2: expensive and time consuming for the factory.
• 18:42
  Speaker 1: So if a factory forces a ten thousand unit minimum
• 18:45
  Speaker 1: on you and you only have so much starting capital,
• 18:47
  Speaker 1: I mean you are basically forced to put all your
• 18:49
  Speaker 1: eggs in one basket.
• 18:50
  Speaker 2: You blow your entire budget. Stocking ten thousand bottles of
• 18:53
  Speaker 2: just one generic dry cough suppressant, which we established is
• 18:57
  Speaker 2: a terrible idea, terrible think about what we discussed earlier.
• 19:00
  Speaker 2: To actually play the game and keep the pediatricians happy,
• 19:04
  Speaker 2: you cannot just stalk one product. You need the wet
• 19:07
  Speaker 2: cough formula, the dry cough formula, the infant drops, the
• 19:10
  Speaker 2: older kid bottles, and the different toddler flavors.
• 19:14
  Speaker 1: Because if you only have one formula, the doctor just
• 19:16
  Speaker 1: sends the patient elsewhere, you lose the prescription.
• 19:19
  Speaker 2: Exactly. So, by lowering the MOQ to just five hundred
• 19:23
  Speaker 2: or one thousand units per sess, you a manufacturer, completely
• 19:27
  Speaker 2: changes the economics for a franchise partner. It gives them flexibility,
• 19:30
  Speaker 2: huge flexibility. Instead of buying ten thousand units of one drug,
• 19:34
  Speaker 2: that partner can buy five hundred units of twenty different
• 19:38
  Speaker 2: highly specialized dregs.
• 19:39
  Speaker 1: Oh I see.
• 19:40
  Speaker 2: It allows them to stalk the entire necessary spectrum of
• 19:43
  Speaker 2: chemical formulations and age ranges without tying up all their
• 19:47
  Speaker 2: capital and massive risky bulk orders. It drastically lowers the
• 19:51
  Speaker 2: barrier to entry while ensuring they actually have the exact
• 19:54
  Speaker 2: right perfectly flavored product for every single prescription a doctor
• 19:58
  Speaker 2: might write.
• 19:58
  Speaker 1: That is brilliant. What does this all mean for us?
• 20:01
  Speaker 1: Let's bring this all together.
• 20:02
  Speaker 2: Let's do it.
• 20:02
  Speaker 1: What we've learned from digging into these sources today is
• 20:05
  Speaker 1: the pediatric COPS syrup isn't just medicine in a bottle.
• 20:09
  Speaker 1: It is an incredibly delicate, high stakes biological and economic ecosystem.
• 20:15
  Speaker 2: It really is.
• 20:16
  Speaker 1: You have to master the precise chemistry. You have to
• 20:19
  Speaker 1: understand when to deploy chemical scissors to clear congestion and
• 20:23
  Speaker 1: when to soothe the nervous system with suppressants.
• 20:26
  Speaker 2: And you can't mix them up never.
• 20:28
  Speaker 1: And then you have to navigate the age specific engineering,
• 20:31
  Speaker 1: managing concentrations from microdrops all the way to large volumes.
• 20:34
  Speaker 1: And above all of that, you have to achieve critical
• 20:37
  Speaker 1: consumer compliance by passing that unforgiving Toddler taste test.
• 20:42
  Speaker 2: The ultimate hurdle, right, and all this.
• 20:44
  Speaker 1: Is really only made possible for franchise partners through agile
• 20:48
  Speaker 1: manufacturing supply chains like PD events that offer those low
• 20:51
  Speaker 1: minimum mortar quantities, allowing them to actually afford to participate
• 20:55
  Speaker 1: in this complex web.
• 20:57
  Speaker 2: It really is a masterclass in how multiple distinct disciple.
• 21:00
  Speaker 2: I mean human biology, behavioral psychology, and factory floor, supply
• 21:04
  Speaker 2: chain logistics, how they all have to align perfectly to
• 21:07
  Speaker 2: create a single successful product outcome.
• 21:09
  Speaker 1: It really makes you look at that seemingly simple pharmacy
• 21:13
  Speaker 1: asle in a completely different way. You kind of respect
• 21:16
  Speaker 1: the gauntlet that little bottle had to run just to
• 21:18
  Speaker 1: get there.
• 21:19
  Speaker 2: It changes your perspective entirely, and it actually raises an
• 21:21
  Speaker 2: interesting question that I think we should leave you with today,
• 21:24
  Speaker 2: something to just maul over on your own. Oh I
• 21:26
  Speaker 2: love these What is it think about that lightning fast,
• 21:30
  Speaker 2: unforgiving feedback loop we discussed, the one driven entirely by
• 21:34
  Speaker 2: a fussy toddler's sense of taste. If the ultimate financial
• 21:38
  Speaker 2: success of a highly regulated, millions of dollars scientifically advanced
• 21:42
  Speaker 2: pharmaceutical product is secretly dictated by whether a child likes
• 21:46
  Speaker 2: the flavor, what other massive, serious data driven industries in
• 21:51
  Speaker 2: our daily lives are actually governed by the simplest, most
• 21:54
  Speaker 2: emotional user experiences.
• 21:56
  Speaker 1: Oh wow, that is a fascinating thought to take with you.
• 21:59
  Speaker 1: The user experience always wins, even in.
• 22:02
  Speaker 2: Medicine, it always does.
• 22:03
  Speaker 1: Thanks for joining us on this deep tive. We'll catch
• 22:05
  Speaker 1: you next time,